PVI
BIIB icon

Pura Vida Investments’s Biogen BIIB Stock Holding History

Pura Vida Investments’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-103,400
Closed -$28.6M – 94
2022
Q4 		$28.6M Sell
103,400
-119,600
-54% -$33.8M 1.48% 18
2022
Q3 		$59.5M Sell
223,000
-125,900
-36% -$26.7M 3.45% 2
2022
Q2 		$71.2M Hold
348,900
– – 4.13% 2
2022
Q1 		$73.5M Buy
348,900
+122,200
+54% +$26.6M 2.38% 8
2021
Q4 		$54.4M Buy
226,700
+197,300
+671% +$50.7M 1.97% 8
2021
Q3 		$8.32M Sell
29,400
-600
-2% -$197K 0.25% 110
2021
Q2 		$10.4M Buy
+30,000
New +$9.09M 0.32% 72

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pura Vida Investments's BIIB Position: Q1 2023 in Review

Pura Vida Investments sold out of Biogen (BIIB) in Q1 2023, closing a stake of 62,720 shares — an estimated $17.4M sold.

Pura Vida Investments first reported a position in BIIB in Q2 2015 and held it in 6 quarters. The position peaked at $31M in Q1 2022. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2023.

  • Pura Vida Investments reported no remaining Biogen position as of Q1 2023 after selling out during the quarter.
  • Pura Vida Investments sold 62,720 Biogen shares in Q1 2023, an estimated $17.4M.
  • Pura Vida Investments first reported a position in Biogen in Q2 2015 and held it in 6 quarters.
  • Pura Vida Investments's Biogen position peaked at $31M in Q1 2022.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2023.

Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.